These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. COVID-19 and Kawasaki Disease: Finding the Signal in the Noise. Schroeder AR; Wilson KM; Ralston SL Hosp Pediatr; 2020 Oct; 10(10):e1-e3. PubMed ID: 32404331 [No Abstract] [Full Text] [Related]
67. Cutaneous manifestations of COVID-19. Wang CJ; Worswick S Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560783 [TBL] [Abstract][Full Text] [Related]
68. Paediatric inflammatory multisystem syndrome: What should we look out for in South Africa? Hendricks CL; Mustafa F; Green RJ; Pepper MS S Afr Med J; 2020 Aug; 110(9):832-834. PubMed ID: 32880261 [No Abstract] [Full Text] [Related]
69. Pulsed methylprednisolone for multisystem inflammatory syndrome in a Japanese boy. Okada T; Akashi M; Oku T; Shinabe Y; Yokota I Pediatr Int; 2022 Jan; 64(1):e15303. PubMed ID: 36329655 [No Abstract] [Full Text] [Related]
70. A case of multisystem inflammatory syndrome in an African adolescent male: case report. Moodley P; Tsitsi JML; Reddy DL; Debising M; Ickinger C Pan Afr Med J; 2021; 38():174. PubMed ID: 33995781 [TBL] [Abstract][Full Text] [Related]
72. An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19. Shaigany S; Gnirke M; Guttmann A; Chong H; Meehan S; Raabe V; Louie E; Solitar B; Femia A Lancet; 2020 Jul; 396(10246):e8-e10. PubMed ID: 32659211 [No Abstract] [Full Text] [Related]
73. Pediatric Multisystemic Inflammatory Syndrome Temporarily associated with COVID-19: Clinical characteristics and management in a Pediatric Critical Care Unit. Yagnam R F; Izquierdo C G; Villena M R; González M C; Drago-T M Andes Pediatr; 2021 Jun; 92(3):395-405. PubMed ID: 34479246 [TBL] [Abstract][Full Text] [Related]
74. Recommendations for the initial management of multisystem inflammatory syndrome temporally related to COVID-19, in children and adolescents. Kohn-Loncarica G; Fustiñana A; Díaz-Rubio F; Jaramillo-Bustamante JC; González-Dambrauskas S; Vásquez-Hoyos P; Fernández-Sarmiento J; González G; Mansur A; Ponce J; Jabornisky R Arch Argent Pediatr; 2020 Dec; 118(6):e514-e526. PubMed ID: 33231054 [TBL] [Abstract][Full Text] [Related]
75. Multisystem Inflammatory Disease in Children During the First Year of the COVID-19 Pandemic. Evans SM; Harris-Kober S; Kamboj A; Stankovic C; DeLaroche AM Clin Pediatr (Phila); 2022 Feb; 61(2):127-132. PubMed ID: 34875895 [No Abstract] [Full Text] [Related]
76. Multisystem Inflammatory Syndrome With Pericardial Tamponade in COVID-19: A Case Report. Jamee A; Abotaima Z; Muammar I Clin Pediatr (Phila); 2022 Feb; 61(2):112-115. PubMed ID: 34541927 [No Abstract] [Full Text] [Related]
77. Pathophysiological and clinical point of view on Kawasaki disease and MIS-C. Vaňková L; Bufka J; Křížková V Pediatr Neonatol; 2023 Sep; 64(5):495-504. PubMed ID: 37453902 [TBL] [Abstract][Full Text] [Related]
78. Update on SARS-CoV-2 infection in children. Martins MM; Prata-Barbosa A; da Cunha AJLA Paediatr Int Child Health; 2021 Feb; 41(1):56-64. PubMed ID: 33616026 [TBL] [Abstract][Full Text] [Related]
79. Hoarseness as a presenting sign in children with Kawasaki disease. Leuin SC; Shanbhag S; Lago D; Sato Y; Sun X; Jain S; Burns JC; Tremoulet AH Pediatr Infect Dis J; 2013 Dec; 32(12):1392-4. PubMed ID: 23811742 [TBL] [Abstract][Full Text] [Related]